Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Oncogene
|
May 12, 2015
hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
P Trono, F Di Modugno, R Circo, et al.
European Journal of Neurology
|
August 28, 2007
A single question for the rapid screening of restless legs syndrome in the neurological clinical practice
R Ferri, B Lanuzza, F I I Cosentino, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes
David F Woodward, Jenny W Wang, Clayton S Spada, et al.
Experimental Eye Research
|
March 31, 2004
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent
L Smith-Thomas, M Moustafa, C S Spada, et al.
European Journal of Physical and Rehabilitation Medicine
|
December 22, 2025
Long-lasting neurobehavioral disorders after traumatic brain injury: potential predictors and functional outcomes
Matteo G Vascello, Silvia Pizzighello, Rosalia Zangari, et al.
Oncology
|
July 16, 2005
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study
S Palmeri, M Vaglica, S Spada, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 1998
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study
S Palmeri, M Meli, M Danova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 20, 2011
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression
Filippo Caraci, Paolo Bosco, Maria Signorelli, et al.
Leukemia
|
December 24, 2016
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
F Gay, S Oliva, M T Petrucci, et al.
Leukemia
|
February 23, 2016
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
A Larocca, S Bringhen, M T Petrucci, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Oncogene
|
May 12, 2015
hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
P Trono, F Di Modugno, R Circo, et al.
European Journal of Neurology
|
August 28, 2007
A single question for the rapid screening of restless legs syndrome in the neurological clinical practice
R Ferri, B Lanuzza, F I I Cosentino, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes
David F Woodward, Jenny W Wang, Clayton S Spada, et al.
Experimental Eye Research
|
March 31, 2004
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent
L Smith-Thomas, M Moustafa, C S Spada, et al.
European Journal of Physical and Rehabilitation Medicine
|
December 22, 2025
Long-lasting neurobehavioral disorders after traumatic brain injury: potential predictors and functional outcomes
Matteo G Vascello, Silvia Pizzighello, Rosalia Zangari, et al.
Oncology
|
July 16, 2005
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study
S Palmeri, M Vaglica, S Spada, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 1998
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study
S Palmeri, M Meli, M Danova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 20, 2011
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression
Filippo Caraci, Paolo Bosco, Maria Signorelli, et al.
Leukemia
|
December 24, 2016
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
F Gay, S Oliva, M T Petrucci, et al.
Leukemia
|
February 23, 2016
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
A Larocca, S Bringhen, M T Petrucci, et al.
Page
of 12